NAIP7 inhibitors belong to a class of chemical compounds that primarily target the NAIP7 protein, which plays a significant role in various cellular processes and pathways. NAIP7, short for Neuronal Apoptosis Inhibitory Protein 7, is a member of the Inhibitor of Apoptosis (IAP) family of proteins, which are known for their involvement in regulating cell survival and apoptosis. These inhibitors specifically interact with NAIP7, modulating its activity or expression levels. NAIP7 itself is a key player in the cellular response to stress, particularly in situations that trigger apoptosis or programmed cell death. By inhibiting NAIP7, these compounds can potentially impact the delicate balance between cell survival and cell death.
NAIP7 inhibitors are of particular interest in the field of molecular biology and cell biology research. Scientists use these inhibitors as valuable tools to better understand the intricate mechanisms underlying apoptosis and cellular stress responses. Additionally, by investigating the effects of NAIP7 inhibition, researchers aim to uncover potential insights into the regulation of cell survival, which can have broader implications in various pathological conditions. The primary utility of NAIP7 inhibitors currently lies in their use as experimental reagents to elucidate the complex and intricate pathways that govern cell fate decisions and apoptosis regulation. These inhibitors offer a means to explore the fundamental biology of cellular processes and may contribute to the development of novel strategies for addressing various cellular dysregulations in the future.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Glyburide (Glibenclamide) | 10238-21-8 | sc-200982 sc-200982A sc-200982D sc-200982B sc-200982C | 1 g 5 g 25 g 100 g 500 g | $45.00 $60.00 $115.00 $170.00 $520.00 | 36 | |
An inhibitor of the NLRP inflammasome, which may affect NAIP7's role in inflammatory processes. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Targets NF-kB signaling, potentially influencing NAIP7's regulatory pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
Inhibits NF-kB activation; may indirectly affect NAIP proteins involved in immune responses. | ||||||
Anakinra | 143090-92-0 | sc-507486 | 10 mg | $795.00 | ||
An IL-1 receptor antagonist which may modulate NAIP7's activity indirectly as part of the inflammasome complex. | ||||||
Andrographolide | 5508-58-7 | sc-205594 sc-205594A | 50 mg 100 mg | $15.00 $39.00 | 7 | |
Inhibits NF-kB activation, could indirectly affect NAIP7's role in signaling pathways. | ||||||
Capsazepine | 138977-28-3 | sc-201098 sc-201098A | 5 mg 25 mg | $145.00 $450.00 | 11 | |
A TRPV1 antagonist that can modulate inflammatory processes, potentially affecting NAIP7. | ||||||
Pyrrolidinedithiocarbamic acid ammonium salt | 5108-96-3 | sc-203224 sc-203224A | 5 g 25 g | $32.00 $63.00 | 11 | |
A metal chelator that inhibits NF-kB, possibly altering NAIP7-related pathways. | ||||||
NFκB Activation Inhibitor II, JSH-23 | 749886-87-1 | sc-222061 sc-222061C sc-222061A sc-222061B | 5 mg 10 mg 50 mg 100 mg | $210.00 $252.00 $1740.00 $1964.00 | 34 | |
Blocks NF-kB nuclear translocation, potentially affecting NAIP7's associated pathways. | ||||||
VER 155008 | 1134156-31-2 | sc-358808 sc-358808A | 10 mg 50 mg | $199.00 $825.00 | 9 | |
Inhibits IKK complex affecting NF-kB activation, could influence NAIP7's role in the immune response. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
An isothiocyanate that inhibits NF-kB signaling, which may impact NAIP7 indirectly. | ||||||